Suppr超能文献

YKL-40 在急性和慢性损伤中 CD14⁺ 肝细胞中的表达。

YKL-40 expression in CD14⁺ liver cells in acute and chronic injury.

机构信息

Department of Physiology, CUCS, University of Guadalajara, Guadalajara, Jalisco 44340, México.

出版信息

World J Gastroenterol. 2011 Sep 7;17(33):3830-5. doi: 10.3748/wjg.v17.i33.3830.

Abstract

AIM

To demonstrate that CD14⁺ cells are an important source of the growth factor YKL-40 in acute and chronic liver damage.

METHODS

Rats were inoculated with one dose of CCl(4) to induce acute damage. Liver biopsies were obtained at 0, 6, 12, 24, 48 and 72 h. For chronic damage, CCl(4) was administered three days per week for 6 or 8 wk. Tissue samples were collected, and cellular populations were isolated by liver digestion and purified by cell sorting. YKL-40 mRNA and protein expression were evaluated by real-time polymerase chain reaction and western blot.

RESULTS

Acute liver damage induced a rapid increase of YKL-40 mRNA beginning at 12 h. Expression peaked at 24 h, with a 26-fold increase over basal levels. By 72 h however, YKL-40 expression levels had nearly returned to control levels. On the other hand, chronic damage induced a sustained increase in YKL-40 expression, with 7- and 9-fold higher levels at 6 and 8 wk, respectively. The pattern of YKL-40 expression in different subpopulations showed that CD14⁺ cells, which include Kupffer cells, are a source of YKL-40 after acute damage at 72 h [0.09 relative expression units (REU)] as well as after chronic injury at 6 wk (0.11 REU). Hepatocytes, in turn, accounted for 0.06 and 0.01 REU after 72 h (acute) or 6 wk (chronic), respectively. The rest of the CD14⁻ cells (including T lymphocytes, B lymphocytes, natural killer and natural killer T cells) yielded 0.07 and 0.15 REU at 72 h and 6 wk, respectively. YKL-40 protein expression in liver was detected at 72 h as well as 6 and 8 wk, with the highest expression relative to controls (11-fold; P ≤ 0.05) seen at 6 wk. Macrophages were stimulated by lipopolysaccharide. We demonstrate that under these conditions, these cells showed maximum expression of YKL-40 at 12 h, with P < 0.05 compared with controls.

CONCLUSION

Hepatic CD14⁺ cells are an YKL-40 mRNA and protein source in acute and chronic liver injury, with expression patterns similar to growth factors implicated in inflammation-fibrogenesis.

摘要

目的

证明 CD14⁺细胞是急性和慢性肝损伤中生长因子 YKL-40 的重要来源。

方法

用 CCl(4) 单次注射诱导急性损伤,分别于 0、6、12、24、48 和 72 h 取肝活检。慢性损伤时,CCl(4)每周 3 天给药,共 6 或 8 周。采集组织样本,通过肝消化分离细胞群,并用细胞分选进行纯化。用实时聚合酶链反应和蛋白质印迹法评估 YKL-40 mRNA 和蛋白表达。

结果

急性肝损伤 12 h 内迅速诱导 YKL-40 mRNA 增加,24 h 达高峰,较基础水平增加 26 倍。然而,72 h 时 YKL-40 表达水平几乎恢复到对照水平。另一方面,慢性损伤诱导 YKL-40 持续表达增加,6 周和 8 周时分别增加 7 倍和 9 倍。不同亚群中 YKL-40 表达模式表明,CD14⁺细胞(包括库普弗细胞)是急性损伤后 72 h (0.09 相对表达单位 [REU])和慢性损伤后 6 周(0.11 REU)YKL-40 的来源。相反,肝细胞在 72 h (急性)或 6 周(慢性)时分别占 0.06 和 0.01 REU。其余 CD14⁻细胞(包括 T 淋巴细胞、B 淋巴细胞、自然杀伤细胞和自然杀伤 T 细胞)在 72 h 和 6 周时分别产生 0.07 和 0.15 REU。肝内也检测到 YKL-40 蛋白表达,72 h 以及 6 周和 8 周时均高于对照组(11 倍;P ≤ 0.05),6 周时最高。用脂多糖刺激巨噬细胞,我们证明在这些条件下,这些细胞在 12 h 时表现出 YKL-40 的最大表达,与对照组相比 P < 0.05。

结论

肝 CD14⁺细胞是急性和慢性肝损伤中 YKL-40 mRNA 和蛋白的来源,其表达模式与参与炎症纤维化的生长因子相似。

相似文献

1
YKL-40 expression in CD14⁺ liver cells in acute and chronic injury.
World J Gastroenterol. 2011 Sep 7;17(33):3830-5. doi: 10.3748/wjg.v17.i33.3830.
2
Cooperation of liver cells in health and disease.
Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. doi: 10.1007/978-3-642-56553-3.
3
The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress.
J Biol Chem. 2010 Sep 24;285(39):29817-25. doi: 10.1074/jbc.M110.103416. Epub 2010 Jul 22.
4
YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation.
Methods Mol Biol. 2009;511:159-84. doi: 10.1007/978-1-59745-447-6_7.
5
The significance of YKL-40 protein in liver fibrosis.
Inflamm Res. 2014 Apr;63(4):249-54. doi: 10.1007/s00011-013-0698-9. Epub 2014 Jan 19.
6
The chitinase-like proteins breast regression protein-39 and YKL-40 regulate hyperoxia-induced acute lung injury.
Am J Respir Crit Care Med. 2010 Oct 1;182(7):918-28. doi: 10.1164/rccm.200912-1793OC. Epub 2010 Jun 17.
10
YKL-40--a novel biomarker in clinical practice?
Folia Med (Plovdiv). 2009 Jan-Mar;51(1):5-14.

引用本文的文献

1
Role of chitinase-3-like protein 1 in liver diseases: A comprehensive review.
Genes Dis. 2025 Apr 24;12(6):101653. doi: 10.1016/j.gendis.2025.101653. eCollection 2025 Nov.
6
CHI3L1 promotes myocardial fibrosis via regulating lncRNA TUG1/miR-495-3p/ETS1 axis.
Apoptosis. 2023 Oct;28(9-10):1436-1451. doi: 10.1007/s10495-023-01859-9. Epub 2023 Jun 7.
7
Chitinase-Like Protein Ym2 (Chil4) Regulates Regeneration of the Olfactory Epithelium via Interaction with Inflammation.
J Neurosci. 2021 Jun 30;41(26):5620-5637. doi: 10.1523/JNEUROSCI.1601-20.2021. Epub 2021 May 20.

本文引用的文献

2
Post-transcriptional control of cytokine production.
Nat Immunol. 2008 Apr;9(4):353-9. doi: 10.1038/ni1584.
3
Innate immune response and hepatic inflammation.
Semin Liver Dis. 2007 Nov;27(4):339-50. doi: 10.1055/s-2007-991511.
5
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.
World J Gastroenterol. 2006 Jun 21;12(23):3682-94. doi: 10.3748/wjg.v12.i23.3682.
6
The liver as an immunological organ.
Hepatology. 2006 Feb;43(2 Suppl 1):S54-62. doi: 10.1002/hep.21060.
10
Circulating YKL-40 levels during human endotoxaemia.
Clin Exp Immunol. 2005 May;140(2):343-8. doi: 10.1111/j.1365-2249.2005.02763.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验